Genenta Science S.p.A.
GNTA
$4.25
$0.07721.85%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.36M | 5.32M | 5.26M | 5.49M | 5.69M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.56M | 10.42M | 10.22M | 11.49M | 12.69M |
| Operating Income | -10.56M | -10.42M | -10.22M | -11.49M | -12.69M |
| Income Before Tax | -9.64M | -9.67M | -9.65M | -11.16M | -12.59M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.64 | -9.67 | -9.65 | -11.16 | -12.59 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.64M | -9.67M | -9.65M | -11.16M | -12.59M |
| EBIT | -10.56M | -10.42M | -10.22M | -11.49M | -12.69M |
| EBITDA | -10.52M | -10.38M | -10.18M | -11.45M | -12.64M |
| EPS Basic | -0.53 | -0.53 | -0.53 | -0.61 | -0.69 |
| Normalized Basic EPS | -0.33 | -0.33 | -0.33 | -0.38 | -0.43 |
| EPS Diluted | -0.53 | -0.53 | -0.53 | -0.61 | -0.69 |
| Normalized Diluted EPS | -0.33 | -0.33 | -0.33 | -0.38 | -0.43 |
| Average Basic Shares Outstanding | 73.09M | 73.02M | 72.95M | 72.91M | 72.87M |
| Average Diluted Shares Outstanding | 73.09M | 73.02M | 72.95M | 72.91M | 72.87M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |